SOA University To Collaborate With US Firm For Natural Medicines

BHUBANESWAR: SOA university will take up research collaboration with US-based THINQ Pharma and Ayurvidya Healthcare Innovations for developing drugs from natural and synthetic products to treat difficult diseases.

This was decided at a meeting between SOA founder president Prof Manojranjan Nayak and eminent scientist and president and chief scientific officer of THINQ Pharma and Ayurvidya Healthcare Innovations Mukund S Chorghade in the presence of other scientists on Saturday.

The collaboration aims at developing new drugs and drug products from natural and synthetic origin. Researchers comprising scientists from the US company and drawn from different disciplines of SOA including pharmacy, biotechnology, medical sciences and engineering will constitute the team which will take the project forward.

Chorghade is a fellow of the American Chemical Society (ACS). His research interests are in drug discovery and development, process chemistry derived medicinal chemistry and traditional Indian medicine. He is credited with the discovery of the sterically protected and electronically activated metalloporphyrin catalysts called ‘chemosynthetic artificial livers, which find utility in drug metabolism, valorisation of biomass and environmental remediation. He was accompanied by chief scientist of Indian Institute of Chemical Technology (IICT), Hyderabad Debendra Kumar Mohapatra.

Director of SOA’s Centre for Nano Sciences and Nano Technology Prof Kulamani Parida, director of Bio-fuel and Bio-processing Research Centre Prof Lala Bihari Sukla and director of Centre for Industrial Biotechnology Prof Hruday Nath Thatoi were present among others during the discussion.

Related Posts

  • Pharma
  • July 13, 2024
  • 103 views
Telangana DCA Seizes Overpriced Anti-Cancer Medicine In Karimnagar

Hyderabad: Drugs Control Administration officials seized ‘Dacazee 500 Injection’ (Dacarbazine Injection IP 500 mg), during the raids carried out on 11th and 12th July, 2024, at a medical shop located in…

  • Pharma
  • July 13, 2024
  • 82 views
Drug Price Regulation Leads To Decline In Availability Of Essential Medicines, Study Finds

Kolkata: The Drug Price Control Order (DPCO) 2013, India’s key drug regulation aimed at making essential medicines more affordable, has inadvertently led to a decline in the availability of these…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Telangana DCA Seizes Overpriced Anti-Cancer Medicine In Karimnagar

Telangana DCA Seizes Overpriced Anti-Cancer Medicine In Karimnagar

Drug Price Regulation Leads To Decline In Availability Of Essential Medicines, Study Finds

Drug Price Regulation Leads To Decline In Availability Of Essential Medicines, Study Finds

EMA Warns Of Anaphylactic Reactions To MS Drug

EMA Warns Of Anaphylactic Reactions To MS Drug

14 Barred Patanjali Products Sold Across Counter At Dedicated Stores

14 Barred Patanjali Products Sold Across Counter At Dedicated Stores

Mumbai: FDA Conducts Raids At Three Different Locations In Vasai, Seized Ayurvedic Drugs Worth Rs 1.41 Crore

Mumbai: FDA Conducts Raids At Three Different Locations In Vasai, Seized Ayurvedic Drugs Worth Rs 1.41 Crore

Telangana DCA Raids 2 Places, Seizes Illegally Stocked And Overpriced Medicines

Telangana DCA Raids 2 Places, Seizes Illegally Stocked And Overpriced Medicines